Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.COPH.2007.10.005PMID 18032109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simple but not simpler

  2009cited by this paper
• Poly(ADP-ribose) polymerase

  2007cited by this paper
• Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion

  2007cited by this paper
• Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.

  2007cited by this paper
• Activation of Poly(ADP)-ribose Polymerase (PARP-1) Induces Release of the Pro-inflammatory Mediator HMGB1 from the Nucleus*

  2007cited by this paper
• Oxygen Sensing : Life and Death of a Cell Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation

  2007cited by this paper
• High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo

  2007cited by this paper
• Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?

  2006cited by this paper
• Recommendations of the National Heart, Lung, and Blood Institute Working Group on Cerebrovascular Biology and Disease

  2006cited by this paper
• Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.

  2006cited by this paper
• Poly(ADP-ribosyl)ation regulates heat shock factor-1 activity and the heat shock response in murine fibroblasts.

  2006cited by this paper
• Anti‐inflammatory effects of PJ34, a poly(ADP‐ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice

  2006cited by this paper
• Poly(ADP-ribose) (PAR) polymer is a death signal

  2006cited by this paper
• Poly(ADP-ribose): novel functions for an old molecule

  2006cited by this paper
• Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death

  2006cited by this paper
• Cerebral Endothelial Cell Apoptosis after Ischemia—Reperfusion: Role of PARP Activation and AIF Translocation

  2005cited by this paper
• Poly(ADP-ribosyl)ation and stroke.

  2005cited by this paper
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

  2005cited by this paper
• Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures.

  2005cited by this paper
• Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model.

  2005cited by this paper
• Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function

  2005cited by this paper
• Poly(ADP‐ribose)

  2005cited by this paper
• Nuclear Poly(ADP-ribose) Polymerase-1 Rapidly Triggers Mitochondrial Dysfunction*

  2005cited by this paper
• NAD+ as a metabolic link between DNA damage and cell death

  2005cited by this paper
• “Simple but not simpler”: toward a unified picture of energy requirements in cell death

  2005cited by this paper
• Poly(ADP-ribose)polymerase inhibition - where now?

  2005cited by this paper
• Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

  2005cited by this paper
• Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death1

  2005cited by this paper
• TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP‐ribose) polymerase

  2004cited by this paper
• PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development.

  2004cited by this paper
• Differential role of poly(ADP-ribose) polymerase-1in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro.

  2004cited by this paper
• Critical Role of the Automodification of Poly(ADP-ribose) Polymerase-1 in Nuclear Factor-κB-dependent Gene Expression in Primary Cultured Mouse Glial Cells*

  2004cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders

  2003cited by this paper
• Novel Isoquinolinone-Derived Inhibitors of Poly(ADP-ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia

  2003cited by this paper
• Poly(ADP-Ribose) Polymerase Impairs Early and Long-Term Experimental Stroke Recovery

  2002cited by this paper
• Comet Assay as a Novel Approach for Studying DNA Damage in Focal Cerebral Ischemia: Differential Effects of NMDA Receptor Antagonists and Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited.

  2002cited by this paper
• Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia

  2002cited by this paper
• Tricarboxylic Acid Cycle Substrates Prevent PARP-Mediated Death of Neurons and Astrocytes

  2002cited by this paper
• Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor

  2002cited by this paper
• Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia

  2001cited by this paper
• Turnover of oxidatively damaged nuclear proteins in BV‐2 microglial cells is linked to their activation state by poly(ADP‐ribose)polymerase

  2001cited by this paper
• Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

  1999cited by this paper
• Poly (ADP-ribose) polymerase, nitric oxide and cell death.

  1999cited by this paper
• Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

  1998cited by this paper
• Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase

  1997cited by this paper
• Poly(ADP‐ribose) polymerase: Early involvement in glutamate‐induced neurotoxicity in cultured cerebellar granule cells

  1994cited by this paper
• Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

  1994cited by this paper
• Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus.

  1993cited by this paper
• Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage

  1990cited by this paper
• Free radicals and brain damage.

  1989cited by this paper
• Poly(ADP-ribose) in the cellular response to DNA damage.

  1985cited by this paper
• Thresholds in cerebral ischemia - the ischemic penumbra.

  1981cited by this paper
• Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme.

  1963cited by this paper

• Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation.

  2026cites this paper
• Herkinorin ameliorates neuronal damage in a pentylenetetrazol-induced epilepsy rat model through altering microglial and astrocytic activation by inhibiting PARP1 and NF-κB.

  2025cites this paper
• Involvement of Calpain in Neurovascular Unit Damage through Up-regulating PARP-NF-κB Signaling during Experimental Ischemic Stroke

  2024cites this paper
• Cell Senescence and the DNA Single-Strand Break Damage Repair Pathway

  2024cites this paper
• PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice.

  2024cites this paper
• Resveratrol Preconditioning Downregulates PARP1 Protein to Alleviate PARP1-Mediated Cell Death Following Cerebral Ischemia

  2023cites this paper
• Functional genetic variation in 3’UTR of PARP1 indicates a decreased risk and a better severity of ischemic stroke

  2022cites this paper
• PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination

  2021cites this paper
• Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples

  2021cites this paper
• Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting

  2021cites this paper
• New insights into targeting mitochondria in ischemic injury

  2021cites this paper
• Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats

  2020cites this paper
• Antiapoptotic and Anti-Inflammatory Effects of CPCGI in Rats with Traumatic Brain Injury

  2020cites this paper
• Poly (ADP-ribose) induces α-synuclein aggregation in neuronal-like cells and interacts with phosphorylated α-synuclein in post mortem PD samples

  2020cites this paper
• Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.

  2020cites this paper
• Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress

  2020cites this paper
• NDT_A_281530 2975..2987

  2020cites this paper
• Interface of DNA Repair and Metabolism

  2020cites this paper
• ADP-ribosylation: from molecular mechanisms to human disease

  2019cites this paper
• Targeting NAD+ Metabolism to Enhance Radiation Therapy Responses.

  2019cites this paper
• Tannic Acid-induced Modulation of Poly(ADP-Ribose) Glycohydrolase and NAD+ Content in Rat Liver and Thymocyte Nuclei

  2019cites this paper
• Mild hypothermia protects neurons against oxygen glucose deprivation via poly (ADP-ribose) signaling

  2019cites this paper
• DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.

  2019cites this paper
• Why is NMNAT Protective against Neuronal Cell Death and Axon Degeneration, but Inhibitory of Axon Regeneration?

  2019cites this paper
• Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke

  2018cites this paper
• miR-448 targets Rab2B and is pivotal in the suppression of pancreatic cancer

  2018cites this paper
• Ischemic stroke across sexes: what is the status quo?

  2018cites this paper
• Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases

  2018cites this paper
• Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

  2018cites this paper
• Nitric Oxide Signaling in Neurodegeneration and Cell Death.

  2018cites this paper
• Nonsyndromic cerebellar ataxias associated with disorders of DNA single-strand break repair.

  2018cites this paper
• Cell death in pure-neuronal and neuron-astrocyte mixed primary culture subjected to oxygen-glucose deprivation: The contribution of poly(ADP-ribose) polymerases and caspases

  2018cites this paper
• Ischemic stroke across sexes: What is the status quo?

  2018cites this paper
• Mitochondrial Mechanisms of Neuronal Cell Death: Potential Therapeutics.

  2017cites this paper
• The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds

  2017cites this paper
• The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning

  2017influential citation
• Alpha-synuclein alters differently gene expression of Sirts, PARPs and other stress response proteins: implications for neurodegenerative disorders

  2017cites this paper
• Sex differences in ischaemic stroke: potential cellular mechanisms.

  2017cites this paper
• Effects of Poly(ADP-Ribose) Polymerase-1 Inhibition in a Neonatal Rodent Model of Hypoxic-Ischemic Injury

  2017cites this paper
• Deficiency of Parkinson’s disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation

  2017cites this paper
• Focusing on claudin‐5: A promising candidate in the regulation of BBB to treat ischemic stroke

  2017cites this paper
• PARP activity and inhibition in fetal and adult oligodendrocyte precursor cells: Effect on cell survival and differentiation.

  2017cites this paper
• A systematic review on potential mechanisms of minocycline in kidney diseases

  2017cites this paper
• Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.

  2017cites this paper
• Selective tumor cell death induced by irradiated riboflavin through recognizing DNA G–T mismatch

  2017cites this paper
• PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier

  2016cites this paper
• PARP inhibition attenuates early brain injury through NF-κB/MMP-9 pathway in a rat model of subarachnoid hemorrhage.

  2016cites this paper
• Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation

  2016cites this paper
• Mechanistic and temporal characterisation of alkyladenine DNA glycosylase-mediated cell death

  2016cites this paper
• Poly(ADP-ribose) polymerase is not involved in the neuroprotection exerted by azithromycin against ischemic stroke in mice.

  2016cites this paper
• Protective effects of PARP inhibitor, PJ34, is related to down-regulation of calpain and NF-κB in a mouse model of TBI.

  2016cites this paper
• Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia

  2016cites this paper
• Concepts and Molecular Aspects in the Polypharmacology of PARP‐1 Inhibitors

  2016cites this paper
• Protection of the brain following cerebral ischemia through the attenuation of PARP-1-induced neurovascular unit damage in rats.

  2015influential citation
• 17-beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP1-dependent cell death via estrogen receptor alpha.

  2015cites this paper
• at the single-cell level identifies glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress.

  2015cites this paper
• NADPH Oxidase-2: Linking Glucose, Acidosis, and Excitotoxicity in Stroke

  2015cites this paper
• Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.

  2015cites this paper
• Assessment at the Single-Cell Level Identifies Neuronal Glutathione Depletion As Both a Cause and Effect of Ischemia-Reperfusion Oxidative Stress

  2015cites this paper
• Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca(2+) Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?

  2015cites this paper
• Sirt1 in cerebral ischemia

  2015cites this paper
• Poly(ADP-ribose) polymerase (PARP)-based pharmacophore model development and its application in designing antitumor inhibitors

  2015cites this paper
• Poly(ADP-ribose) Polymerase-1 Inhibition in Brain Endothelium Protects the Blood—Brain Barrier under Physiologic and Neuroinflammatory Conditions

  2015cites this paper
• Synthesis of Small Molecules Targeting ADP-Ribosyltransferases and Total Synthesis of Resveratrol Based Natural Products

  2015cites this paper
• Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia.

  2014cites this paper
• 17-beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP 1-dependent cell death via estrogen receptor alpha

  2014cites this paper
• PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors.

  2014cites this paper
• Small molecule inhibitors in the treatment of cerebral ischemia

  2014cites this paper
• Effect of cilostazol pretreatment on the PARP/AIF-mediated apoptotic pathway in rat cerebral ischemia-reperfusion models

  2014cites this paper
• Poli(ADP-ribozil) polimeraza u životu i smrti živčanih stanica

  2014cites this paper
• DNA single-strand break repair.

  2014cites this paper
• Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment.

  2013cites this paper
• Novel insights into the neuroendocrine control of inflammation: the role of GR and PARP1

  2013cites this paper
• Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors.

  2013cites this paper
• Effects of Poly (ADP-ribose) Polymerase Inhibitor 3-Aminobenzamide on Blood–Brain Barrier and Dopaminergic Neurons of Rats with Lipopolysaccharide-Induced Parkinson’s Disease

  2013cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013influential citation
• New role of silent information regulator 1 in cerebral ischemia.

  2013cites this paper
• Chloride channel blocker 4,4-diisothiocyanatostilbene-2,2′-disulfonic acid inhibits nitric oxide-induced apoptosis in cultured rat hippocampal neurons

  2013cites this paper
• Expression and activity of PARP family members in the hippocampus during systemic inflammation: their role in the regulation of prooxidative genes.

  2013cites this paper
• Novel insights into the neuroendocrine control of inflammation : the role of GR and PARP 1

  2013cites this paper
• Beneficial Effects of Antecedent Exercise Training on Limb Motor Function and Calpain Expression in a Rat Model of Stroke

  2013cites this paper
• From polypharmacology to target specificity: the case of PARP inhibitors.

  2013cites this paper
• PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.

  2013cites this paper
• Progress on the protective effect of compounds from natural medicines on cerebral ischemia.

  2013cites this paper
• Biological Sex and Mechanisms of Ischemic Brain Injury

  2013cites this paper
• Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.

  2013cites this paper
• Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection.

  2013cites this paper
• Lactuside B decreases aquaporin-4 and caspase-3 mRNA expression in the hippocampus and striatum following cerebral ischaemia-reperfusion injury in rats

  2013cites this paper
• Long‐lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP‐ribose) polymerase

  2012cites this paper
• PARP‐1 deletion promotes subventricular zone neural stem cells toward a glial fate

  2012cites this paper
• Mild activation of poly(ADP‐ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance

  2012cites this paper
• Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer’s Disease

  2012cites this paper
• Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB

  2012cites this paper
• Neuroprotective Effect of Quercetin Against Hydrogen Peroxide-induced Oxidative Injury in P19 Neurons

  2012cites this paper
• Neuroprotective Effect of Phosphocreatine on Focal Cerebral Ischemia-Reperfusion Injury

  2012cites this paper
• Cellular and Molecular Processes of Neuronal Damage and Mechanisms in Neuroprotection and Neuroregeneration— Focus on Brain Ischemia

  2012cites this paper
• Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake.

  2012cites this paper
• Effect of the PARP-1 Inhibitor PJ 34 on Excitotoxic Damage Evoked by Kainate on Rat Spinal Cord Organotypic Slices

  2011cites this paper
• Molecular Mechanisms Underlying Cell Death in Spinal Networks in Relation to Locomotor Activity After Acute Injury in vitro

  2011cites this paper
• Hypothermia protects H9c2 cardiomyocytes from H2O2 induced apoptosis.

  2011cites this paper